Nabriva Therapeutics Raises €15 Million
Nabriva Therapeutics, a Vienna, Austra-based developer of antibiotics for treating resistant pathogens, has raised €15 million in new VC funding. Return backers include Nomura Phase 4 Ventures, HBM Partners, Wellcome Trust, GLS Ventures, and Novartis Venture Fund. The company has now raised a total of €57.4 million since 2006.
29 October 2009•2 mins read
